<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1446" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1446/" /><meta name="ncbi_pagename" content="Greig Cephalopolysyndactyly Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Greig Cephalopolysyndactyly Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Greig Cephalopolysyndactyly Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/06/19" /><meta name="citation_author" content="Leslie G Biesecker" /><meta name="citation_pmid" content="20301619" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1446/" /><meta name="citation_keywords" content="Cephalopolysyndactyly Syndrome" /><meta name="citation_keywords" content="Cephalopolysyndactyly Syndrome" /><meta name="citation_keywords" content="Transcriptional activator GLI3" /><meta name="citation_keywords" content="GLI3" /><meta name="citation_keywords" content="Greig Cephalopolysyndactyly Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Greig Cephalopolysyndactyly Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Leslie G Biesecker" /><meta name="DC.Date" content="2014/06/19" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1446/" /><meta name="description" content="Typical Greig cephalopolysyndactyly syndrome (GCPS) is characterized by preaxial polydactyly or mixed pre- and postaxial polydactyly, true widely spaced eyes, and macrocephaly. Individuals with mild GCPS may have subtle craniofacial findings. The mild end of the GCPS spectrum is a continuum with preaxial polysyndactyly type IV and crossed polydactyly (preaxial polydactyly of the feet and postaxial polydactyly of the hands plus syndactyly of fingers 3-4 and toes 1-3). Individuals with severe GCPS can have seizures, hydrocephalus, and intellectual disability." /><meta name="og:title" content="Greig Cephalopolysyndactyly Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Typical Greig cephalopolysyndactyly syndrome (GCPS) is characterized by preaxial polydactyly or mixed pre- and postaxial polydactyly, true widely spaced eyes, and macrocephaly. Individuals with mild GCPS may have subtle craniofacial findings. The mild end of the GCPS spectrum is a continuum with preaxial polysyndactyly type IV and crossed polydactyly (preaxial polydactyly of the feet and postaxial polydactyly of the hands plus syndactyly of fingers 3-4 and toes 1-3). Individuals with severe GCPS can have seizures, hydrocephalus, and intellectual disability." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1446/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/gcps/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1446/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C9BB7E042304100000000029D0104.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1446_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1446_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/gsd6/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hemochromatosis/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1446_"><span class="title" itemprop="name">Greig Cephalopolysyndactyly Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Cephalopolysyndactyly Syndrome</div><p class="contrib-group"><span itemprop="author">Leslie G Biesecker</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1446_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1446_ai__"><div class="contrib half_rhythm"><span itemprop="author">Leslie G Biesecker</span>, MD<div class="affiliation small">Medical Genomics and Metabolic Genetics Branch<br />National Human Genome Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@bsel" class="oemail">vog.hin.liam@bsel</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">July 9, 2001</span>; Last Update: <span itemprop="dateModified">June 19, 2014</span>.</p><p><em>Estimated reading time: 18 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="gcps.Summary" itemprop="description"><h2 id="_gcps_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Typical Greig cephalopolysyndactyly syndrome (GCPS) is characterized by preaxial polydactyly or mixed pre- and postaxial polydactyly, true widely spaced eyes, and macrocephaly. Individuals with mild GCPS may have subtle craniofacial findings. The mild end of the GCPS spectrum is a continuum with preaxial polysyndactyly type IV and crossed polydactyly (preaxial polydactyly of the feet and postaxial polydactyly of the hands plus syndactyly of fingers 3-4 and toes 1-3). Individuals with severe GCPS can have seizures, hydrocephalus, and intellectual disability.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of GCPS is based on clinical findings and family history. <i>GLI3</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> known to be associated with GCPS; <i>GLI3</i> alterations (i.e., <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> abnormalities involving <i>GLI3</i> or pathogenic variants of <i>GLI3</i>) can be identified in more than 75% of typically <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Elective surgical repair of polydactyly with greatest priority given to correction of preaxial polydactyly of the hands; evaluation and treatment as needed for hydrocephalus or other CNS abnormalities in individuals showing signs of increased intracranial pressure, developmental delay, loss of milestones, and/or seizures.</p><p><i>Surveillance:</i> Monitoring for evidence of occipitofrontal circumference (OFC) increasing faster than normal.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>GCPS either is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner (either as a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GLI3</i> or as a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 7p13 involving <i>GLI3</i>) or occurs as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> or inherited <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement. Individuals with GCPS as the result of a <i>GLI3</i> pathogenic variant may have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent or may have the disorder as the result of a <i>de novo</i> pathogenic variant. The proportion of cases caused by <i>de novo</i> pathogenic variants is unknown. Each child of an individual with a <i>GLI3</i> pathogenic variant has a 50% chance of inheriting the pathogenic variant. Prenatal testing for pregnancies at increased risk is possible if the underlying genetic cause in the family (i.e., deletion of 7p13, balanced chromosome rearrangement, or <i>GLI3</i> pathogenic variant) has been identified. The reliability of ultrasound examination for <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> is unknown.</p></div></div><div id="gcps.Diagnosis"><h2 id="_gcps_Diagnosis_">Diagnosis</h2><p>Major findings of Greig cephalopolysyndactyly syndrome (GCPS) are the following.</p><p><b>Macrocephaly.</b> Occipitofrontal (head) circumference (OFC) is greater than 97th centile compared to appropriate age- and sex-matched normal standards [<a class="bk_pop" href="#gcps.REF.allanson.2009.6">Allanson et al 2009</a>]. Note: An enlarged OFC must be interpreted with caution in families in which a parent (or parents) of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> macrocephaly (OMIM <a href="http://omim.org/entry/153470" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">153470</a>).</p><p>Some individuals with GCPS have a high anterior hairline, and a prominent (or bossed) forehead.</p><p><b>Widely spaced eyes.</b> Interpupillary distance is more than 2 SD above the mean (newborns 27-41 weeks' gestational age or interpupillary distance above the 97th centile (age 0-15 years) or a subjectively increased interpupillary distance [<a class="bk_pop" href="#gcps.REF.hall.2009.29">Hall et al 2009</a>]. Increased inner canthal distance (i.e., telecanthus, or apparent widely spaced eyes) may be present as well but is not as distinctive a finding as increased interpupillary distance. Increased interpupillary distance is often associated with a wide nasal bridge.</p><p><b>Limb anomalies</b></p><ul><li class="half_rhythm"><div><b>Preaxial polydactyly.</b> At least one limb should manifest one of the following [<a class="bk_pop" href="#gcps.REF.biesecker.2009.93">Biesecker et al 2009</a>]:</div><ul><li class="half_rhythm"><div>Preaxial polydactyly (duplication of all or part of the first ray)</div></li><li class="half_rhythm"><div>A markedly broad hallux (visible increase in width of the hallux without an increase in the dorso-ventral dimension)</div></li><li class="half_rhythm"><div>A markedly broad thumb (increased thumb width without increased dorso-ventral dimension)</div></li></ul></li><li class="half_rhythm"><div>Other limbs may manifest preaxial or postaxial polydactyly and some limbs may have five normal digits. The postaxial polydactyly may be type A, type B, or intermediate forms.</div><ul><li class="half_rhythm"><div>Postaxial polydactyly type A (PAP-A) is the presence of a well-formed digit on the ulnar or fibular aspect of the limb.</div></li><li class="half_rhythm"><div>Postaxial polydactyly type B (PAP-B) is the presence of a rudimentary digit or nubbin in the same location. The finding of postaxial polydactyly type B must be evaluated critically when present in an individual of west-central African descent as that feature is a common variant (1% prevalence).</div></li></ul></li><li class="half_rhythm"><div>Some individuals have widening of the first digit apparent only on x-ray. This is difficult to assess when diagnosing a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li><li class="half_rhythm"><div><b>Cutaneous syndactyly.</b> The cutaneous syndactyly may be partial or complete; in occasional severe cases, parts of the distal phalanges may be fused.</div></li></ul><div id="gcps.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>A <b>presumptive diagnosis</b>&#x000a0;* is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with preaxial polydactyly, cutaneous syndactyly of toes 1-3 or fingers 3-4, widely spaced eyes, and macrocephaly.</p><p>Note: The diagnosis should be made with caution in infants with multiple other malformations, especially in the absence of a positive family history.</p><p>A <b>firm diagnosis</b>&#x000a0;* is established in:</p><ul><li class="half_rhythm"><div class="half_rhythm">A <a class="def" href="/books/n/gene/glossary/def-item/first-degree-relative/">first-degree relative</a> of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> for whom the diagnosis has been independently established. The first-degree relative of a proband may be diagnosed as <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> if he/she has pre- or postaxial polydactyly with or without syndactyly or the craniofacial features.</div><div class="half_rhythm">Note: Postaxial polydactyly type B should not be used as a diagnostic criterion for first-degree relatives of persons who are of west-central African descent.</div></li><li class="half_rhythm"><div class="half_rhythm">A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who has features of GCPS and a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GLI3.</i></div></li></ul><p>*&#x000a0;The distinction of <b>presumptive</b> and <b>firm diagnoses</b> is based on data of <a class="bk_pop" href="#gcps.REF.johnston.2005.609">Johnston et al [2005]</a>, who suggested that the clinical criteria were useful but may not be sufficiently specific to warrant a "firm" diagnosis on clinical grounds alone. A small but significant fraction of individuals with features of GCPS do not have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GLI3</i>. This, coupled with the fact that the features of GCPS may be a component of many other syndromes, warrants caution in applying these diagnostic criteria.</p></div><div id="gcps.Testing"><h3>Testing</h3><p><b>Gene.</b>
<i>GLI3</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause Greig cephalopolysyndactyly syndrome.</p><div id="gcps.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Greig Cephalopolysyndactyly Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1446/table/gcps.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gcps.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gcps.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_gcps.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_gcps.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_gcps.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>GLI3</i></td><td headers="hd_h_gcps.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_gcps.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">70%&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_gcps.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>4,&#x000a0;5,&#x000a0;6</sup></td><td headers="hd_h_gcps.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%-10%&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_gcps.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Loss of heterozygosity analysis&#x000a0;<sup>8</sup></td><td headers="hd_h_gcps.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~50%-75%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="gcps.TF.1.1"><p class="no_margin">See <a href="/books/NBK1446/#gcps.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#gcps.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>2. </dt><dd><div id="gcps.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="gcps.TF.1.3"><p class="no_margin"><a class="bk_pop" href="#gcps.REF.johnston.2005.609">Johnston et al [2005]</a></p></div></dd><dt>4. </dt><dd><div id="gcps.TF.1.4"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>5. </dt><dd><div id="gcps.TF.1.5"><p class="no_margin">To date, every person with a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of <i>GLI3</i> has had a different breakpoint and the sizes of the deletions have ranged from one <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> to more than 10 Mb [<a class="bk_pop" href="#gcps.REF.johnston.2007.e59">Johnston et al 2007</a>]. Because <i>GLI3</i> is about 300 kb in size, large deletions may not necessarily alter the signal of any given <i>GLI3</i> <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>, array CGH, or MLPA probe. Therefore, no single testing modality can detect all such deletions and translocations, making it difficult to quote a detection rate for any single testing modality.</p></div></dd><dt>6. </dt><dd><div id="gcps.TF.1.6"><p class="no_margin">Giemsa-banded karyotypes do not detect all deletions, even those on the order of 1 Mb [unpublished observations].</p></div></dd><dt>7. </dt><dd><div id="gcps.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#gcps.REF.johnston.2003.236">Johnston et al [2003]</a></p></div></dd><dt>8. </dt><dd><div id="gcps.TF.1.8"><p class="no_margin">Detects <i>GLI3</i> deletions</p></div></dd></dl></div></div></div></div><div id="gcps.Testing_Strategy"><h3>Testing Strategy</h3><p><b>Confirmation of the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Two salient clinical features should be considered prior to diagnostic testing. The first is the presence of developmental delay or intellectual disability in the proband. The second is a history of recurrent pregnancy losses in the parents of the proband.</p><ul><li class="half_rhythm"><div>For individuals with clinical features consistent with GCPS, and without significant developmental delay or intellectual disability or pregnancy losses in the parents, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>GLI3</i> should be considered first, followed by CGH analysis if no <i>GLI3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified, followed by Giemsa-banded karyotyping if no <i>GLI3</i> pathogenic variant has been identified by the other two methods.</div></li><li class="half_rhythm"><div>If the patient has significant developmental delay or intellectual disability, CGH analysis should be done first, followed by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>GLI3</i>, and then Giemsa-banded karyotyping if no <i>GLI3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified by the other two methods.</div></li><li class="half_rhythm"><div>If there is a family history of parental pregnancy losses, a Giemsa-banded <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> should be considered first, followed by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>GLI3</i> and then CGH.</div></li></ul></div></div><div id="gcps.Clinical_Characteristics"><h2 id="_gcps_Clinical_Characteristics_">Clinical Characteristics</h2><div id="gcps.Clinical_Description"><h3>Clinical Description</h3><p>Several large families have been reported as having a mild form of GCPS with excellent general health and normal longevity.</p><p>Developmental delay, intellectual disability, or seizures appear to be uncommon manifestations (estimated at &#x0003c;10%) of GCPS. These complications are more likely if the child has CNS malformations (rare) or hydrocephalus (uncommon), and they may be more common in individuals with large (&#x0003e;300 kb) deletions that encompass <i>GLI3</i> [<a class="bk_pop" href="#gcps.REF.johnston.2007.e59">Johnston et al 2007</a>].</p></div><div id="gcps.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Individuals who have GCPS associated with a large (&#x0003e;300 kbp) <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> have a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> than those with <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> translocations or single nucleotide variants in <i>GLI3</i> [<a class="bk_pop" href="#gcps.REF.kroisel.2001.243">Kroisel et al 2001</a>, <a class="bk_pop" href="#gcps.REF.johnston.2007.e59">Johnston et al 2007</a>]. Individuals with large deletions appear to have a higher incidence of intellectual disability, seizures, and CNS anomalies. This phenomenon is presumably caused by <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of multiple genes in the vicinity of <i>GLI3</i>.</p><p>Two individuals with a severe GCPS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> that overlaps with acrocallosal syndrome (see <a class="figpopup" href="/books/NBK1446/figure/gcps.F1/?report=objectonly" target="object" rid-figpopup="figgcpsF1" rid-ob="figobgcpsF1">Figure 1</a>) have been found to have a pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant in <i>GLI3</i> [<a class="bk_pop" href="#gcps.REF.elson.2002.804">Elson et al 2002</a>, <a class="bk_pop" href="#gcps.REF.speksnijder.2013.1394">Speksnijder et al 2013</a>].</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figgcpsF1" co-legend-rid="figlgndgcpsF1"><a href="/books/NBK1446/figure/gcps.F1/?report=objectonly" target="object" title="Figure 1" class="img_link icnblk_img figpopup" rid-figpopup="figgcpsF1" rid-ob="figobgcpsF1"><img class="small-thumb" src="/books/NBK1446/bin/gcps-Image001.gif" src-large="/books/NBK1446/bin/gcps-Image001.jpg" alt="Figure 1. A." /></a><div class="icnblk_cntnt" id="figlgndgcpsF1"><h4 id="gcps.F1"><a href="/books/NBK1446/figure/gcps.F1/?report=objectonly" target="object" rid-ob="figobgcpsF1">Figure 1</a></h4><p class="float-caption no_bottom_margin">A. The mutational spectra of GCPS and PHS are distinct. GCPS is caused by pathogenic variants of all types, whereas PHS is only caused by truncating variants and one splice variant that generates a frameshift and a truncation. B. Within the frameshift <a href="/books/NBK1446/figure/gcps.F1/?report=objectonly" target="object" rid-ob="figobgcpsF1">(more...)</a></p></div></div><p>A <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation has been demonstrated on two levels:</p><ul><li class="half_rhythm"><div><b>Class of variant.</b> Pathogenic variants of all classes can cause GCPS, whereas the only class of pathogenic variants that causes the allelic disorder <a href="/books/n/gene/phs/">Pallister-Hall syndrome</a> is frameshifting variants. Haploinsufficiency for GLI3 causes GCPS, whereas truncating variants 3' of the zinc finger <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of <i>GLI3</i> generally cause PHS [<a class="bk_pop" href="#gcps.REF.kang.1997.266">Kang et al 1997</a>] (<a class="figpopup" href="/books/NBK1446/figure/gcps.F1/?report=objectonly" target="object" rid-figpopup="figgcpsF1" rid-ob="figobgcpsF1">Figure 1A</a>).</div></li><li class="half_rhythm"><div><b>Variant position.</b> Among all frameshift variants in <i>GLI3</i>, variants in the first third of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> are only known to cause GCPS (<a class="figpopup" href="/books/NBK1446/figure/gcps.F1/?report=objectonly" target="object" rid-figpopup="figgcpsF1" rid-ob="figobgcpsF1">Figure 1B</a>). Frameshifting variants in the middle third of the gene cause <a href="/books/n/gene/phs/">Pallister-Hall syndrome</a> and uncommonly cause GCPS. Frameshift variants in the final third of the gene cause GCPS. There is no apparent correlation of the variant position within each of the three regions and the severity of the respective phenotypes.</div></li></ul></div><div id="gcps.Penetrance"><h3>Penetrance</h3><p>One case of apparent non-<a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> has been reported [<a class="bk_pop" href="#gcps.REF.debeer.2003.49">Debeer et al 2003</a>]. It is difficult to estimate a rate of non-penetrance from a single instance, but it is probably a small fraction.</p></div><div id="gcps.Anticipation"><h3>Anticipation</h3><p>There is no evidence for genetic <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a> in GCPS.</p></div><div id="gcps.Nomenclature"><h3>Nomenclature</h3><p>The term "Greig syndrome" describes the dyad of widely spaced eyes and macrocephaly. Because that dyad of anomalies is nonspecific, the term should not be used as a synonym for GCPS [<a class="bk_pop" href="#gcps.REF.gorlin.2001">Gorlin et al 2001</a>].</p></div><div id="gcps.Prevalence"><h3>Prevalence</h3><p>GCPS is rare and pan ethnic; the prevalence is unknown. Approximately 100 cases are known to this author. It is suspected that many individuals with preaxial polydactyly with syndactyly and mild craniofacial features are misdiagnosed as having <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> preaxial polydactyly instead of GCPS (see <a href="#gcps.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</a>, <b>PPDIV</b>); however, the distinction may be semantic [<a class="bk_pop" href="#gcps.REF.biesecker.2008.10">Biesecker 2008</a>].</p></div></div><div id="gcps.Genetically_Related_Allelic_Disorde"><h2 id="_gcps_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>Other phenotypes known to be associated with pathogenic variants in <i>GLI3</i>:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/phs/"><b>Pallister-Hall syndrome</b></a>
<b>(PHS)</b> comprises central or postaxial polydactyly, hypothalamic hamartoma, bifid epiglottis, imperforate anus or anal stenosis, and other anomalies. PHS displays a wide range of severity. There is confusion in the literature and it is often wrongly assumed that PHS is severe and Greig cephalopolysyndactyly syndrome is mild. A minority of individuals with PHS show multiple severe anomalies such as pituitary dysplasia with panhypopituitarism and laryngeal clefts or other airway anomalies, which may be life threatening in the neonatal period. However, most individuals with PHS are mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with polydactyly and asymptomatic bifid epiglottis and hypothalamic hamartoma (HH).</div></li><li class="half_rhythm"><div><b>Postaxial polydactyly type A (PAP-A)</b> is not a syndrome but instead a limb malformation limited to the presence of a single, well-formed supernumerary postaxial digit on one or both hands and feet. There is some controversy regarding whether PAP-A is distinct from PHS or is instead a mild variant of PHS with mild, subtle, and asymptomatic bifid epiglottis, hypothalamic hamartoma, anal stenosis, and other signs.</div></li><li class="half_rhythm"><div><b>Preaxial polydactyly type IV (PPD-IV)</b> is essentially GCPS without craniofacial manifestations. Affected individuals typically have the same pattern of syndactyly in the hands and feet as individuals with GCPS.</div></li><li class="half_rhythm"><div><b>Isolated preaxial polydactyly type IV (PPDIV)</b> comprises preaxial polydactyly of the hands and/or feet in the absence of other malformations. The severity of the PPDIV is highly variable [<a class="bk_pop" href="#gcps.REF.everman.2006">Everman 2006</a>]. Because macrocephaly occurs in the general population and is common in GCPS, the presence of macrocephaly in a person with apparently <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> PPDIV may be difficult to interpret.</div></li></ul></div><div id="gcps.Differential_Diagnosis"><h2 id="_gcps_Differential_Diagnosis_">Differential Diagnosis</h2><p>Acrocallosal syndrome (ACLS) (OMIM <a href="http://omim.org/entry/200990" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">200990</a>) includes pre- or postaxial polydactyly, cutaneous syndactyly, agenesis of the corpus callosum (rare in GCPS), widely spaced eyes, macrocephaly, moderate to severe intellectual disability, intracerebral cysts, seizures, and umbilical and inguinal hernias. The disorder appears to be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner [<a class="bk_pop" href="#gcps.REF.koenig.2002.7">Koenig et al 2002</a>] and can be caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>KIF7</i> [<a class="bk_pop" href="#gcps.REF.putoux.2011.601">Putoux et al 2011</a>]. The milder end of the ACLS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> can overlap with the severe end of the GCPS phenotype caused by interstitial deletions of 7p13 that delete <i>GLI3</i> and additional neighboring genes, as discussed in <a href="#gcps.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>.</p><p>Some subtypes of oral-facial-digital syndrome have similar limb malformations [<a class="bk_pop" href="#gcps.REF.gorlin.2001">Gorlin et al 2001</a>]. (See, for example, <a href="/books/n/gene/ofd1/">Oral-Facial-Digital Syndrome Type 1</a>.)</p><p>Craniofrontonasal dysplasia has similar facial features [<a class="bk_pop" href="#gcps.REF.gorlin.2001">Gorlin et al 2001</a>].</p></div><div id="gcps.Management"><h2 id="_gcps_Management_">Management</h2><div id="gcps.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>Most individuals diagnosed with Greig cephalopolysyndactyly syndrome (GCPS) have the craniofacial and limb anomalies only. As for all individuals with malformations, a dysmorphology examination is appropriate to exclude other anomalies.</p><p>Sophisticated imaging, especially of the CNS, is not routinely indicated unless the clinician detects findings or symptoms that specifically indicate such an evaluation.</p><p>Similarly, as most individuals with GCPS have normal development, screening beyond the standard Denver Developmental Screening test is not recommended.</p></div><div id="gcps.Treatment_of_Manifestations"><h3>Treatment of Manifestations&#x000a0;*</h3><p>The author is not aware of craniofacial reconstructive surgery being performed on individuals with GCPS as the widely spaced eyes and macrocephaly are generally not sufficiently severe to warrant surgery.</p><p>Repair of polydactyly should be undertaken on an elective basis. Preaxial polydactyly of the hands is considered to be a higher priority for surgical correction than postaxial polydactyly of the hand or any type of polydactyly of the foot because of the importance of early and proper development of the prehensile grasp.</p><p>Cutaneous syndactyly of the fingers is usually repaired if it is more than minimal.</p><p>As is true for any malformation of the feet, surgical correction must be carefully considered. Cosmetic benefits and easier fitting of shoes can be outweighed by potential orthopedic complications.</p><p>Seizures are treated symptomatically.</p><p>*&#x000a0;As with the diagnostic criteria (see <a href="#gcps.Diagnosis">Diagnosis</a>), no published data support these recommendations, which are those of the author.</p></div><div id="gcps.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>The only recognized preventable secondary complication may be developmental delay, which may be preventable or ameliorated by early intervention.</p></div><div id="gcps.Surveillance"><h3>Surveillance&#x000a0;*</h3><p>Individuals with an OFC that is increasing faster than normal, signs of increased intracranial pressure, developmental delay, loss of milestones, or seizures should undergo appropriate CNS imaging studies to exclude hydrocephalus, other CNS abnormalities, or cerebral cavernous malformations (seen in some individuals with GCPS and large deletions [<a class="bk_pop" href="#gcps.REF.bilguvar.2007.495">Bilguvar et al 2007</a>; Author, unpublished observations]).</p><p>*&#x000a0;As with the diagnostic criteria (see <a href="#gcps.Diagnosis">Diagnosis</a>), no published data support these recommendations, which are those of the author.</p></div><div id="gcps.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#gcps.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="gcps.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="gcps.Genetic_Counseling"><h2 id="_gcps_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="gcps.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Greig cephalopolysyndactyly syndrome either is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner (as a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GLI3</i> or as a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 7p13 involving <i>GLI3</i>) or occurs as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> or inherited <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement.</p></div><div id="gcps.Risk_to_Family_Members__Autosomal_D"><h3>Risk to Family Members &#x02013; Autosomal Dominant Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Some individuals diagnosed with GCPS have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent and some have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>GLI3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by <i>de novo</i> pathogenic variants is unknown, as the frequency of subtle signs of the disorder in parents has not been thoroughly evaluated and molecular genetic data are insufficient.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a child with GCPS and no known family history of GCPS consist of clinical examination and x-rays of hands and feet unless physical signs suggest the need for other studies (e.g., neuroimaging for possible hydrocephalus in a parent). Molecular genetic testing of the parents is indicated if the <i>GLI3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has been identified.</div></li></ul><p>Note: (1) Although some individuals diagnosed with GCPS have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, the family history may appear to be negative because of failure to recognize the disorder in family members. (2) If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the pathogenic variant and may be mildly/minimally affected.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents:</div><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low.</div></li></ul></li><li class="half_rhythm"><div>Although no instances of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> have been reported, it remains a possibility.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with GCPS has a 50% chance of inheriting the <i>GLI3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Since <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a> is generally low, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> offspring are expected to have clinical findings similar to those of the parent.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the genetic status of the proband's parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members are at risk.</p></div><div id="gcps.Risk_to_Family_Members__Chromosome"><h3>Risk to Family Members &#x02013; Chromosome Rearrangement</h3><p>Greig cephalopolysyndactyly syndrome can be the result of an inherited or <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement.</p><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Parents of a proband with an unbalanced structural <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> constitution (e.g., <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a>) are at risk of having a balanced chromosome rearrangement and should be offered chromosome analysis.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an unbalanced structural <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> constitution depends on the chromosome findings in the parents.</div></li><li class="half_rhythm"><div>If neither parent has a structural <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement, the risk to sibs is negligible.</div></li><li class="half_rhythm"><div>If a parent has a balanced structural <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement, the risk to sibs is increased and depends on the specific chromosome rearrangement and the possibility of other variables.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Offspring of an individual with a balanced or unbalanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement are at risk of having a similar or related rearrangement.</p></div><div id="gcps.Carrier_Detection"><h3>Carrier Detection</h3><p>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement, at-risk family members can be tested by chromosome analysis.</p></div><div id="gcps.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Range of severity.</b> A significant range of severity is associated with the GCPS designation; <a class="def" href="/books/n/gene/glossary/def-item/interfamilial-variability/">interfamilial variability</a> is greater than <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a>: it is unlikely that a family with a mild GCPS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> will have a child <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with severe GCPS. This rule excludes founders who may theoretically be mildly affected because they have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for a <i>GLI3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. If a founder has germ cells with the pathogenic variant, his or her offspring may be affected; the affected offspring would be non-mosaic and thus could have a more severe phenotype than the parent.</p><p>The prognosis for an individual who has no known family history of GCPS should be based on the malformations present in that individual. Literature surveys are not useful for this purpose because reported cases tend to show bias of ascertainment to more severe involvement.</p><p>For individuals with a family history of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members, the prognosis is based on the degree of severity present in the family, as <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a> appears to be low.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with GCPS has clinical evidence of the disorder, the <i>GLI3</i> pathogenic variant is likely <i>de novo</i>. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="gcps.Prenatal_Testing"><h3>Prenatal Testing</h3><p><b>Cytogenetic testing.</b> In pregnancies of a parent with a cytogenetically visible <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 7p13 or a balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement, prenatal testing is possible by chromosome analysis of fetal cells obtained by chorionic villus sampling (CVS) at approximately ten to 12 weeks' gestation or by amniocentesis usually performed at approximately 15 to 18 weeks' gestation.</p><p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p><p><b>Molecular genetic testing.</b> If the <i>GLI3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing of this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or <a class="def" href="/books/n/gene/glossary/def-item/custom-prenatal-testing/">custom prenatal testing</a>.</p><p><b>Ultrasound examination.</b> In pregnancies at 50% risk, prenatal ultrasound examination may detect polydactyly, macrocephaly, or other CNS abnormalities such as hydrocephalus. However, a normal ultrasound examination does not eliminate the possibility of GCPS in the fetus.</p><p><b>Preimplantation genetic diagnosis (PGD)</b> may be an option for some families in which the <i>GLI3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified.</p></div></div><div id="gcps.Resources"><h2 id="_gcps_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=greigcephalopolysyndactylysyndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Greig cephalopolysyndactyly syndrome</a></div></li><li class="half_rhythm"><div><b>Children's Craniofacial Association (CCA)</b></div><div>13140 Coit Road</div><div>Suite 517</div><div>Dallas TX 75240</div><div><b>Phone:</b> 800-535-3643 (toll-free)</div><div><b>Email:</b> contactCCA@ccakids.com</div><div><a href="https://ccakids.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ccakids.org</a></div></li><li class="half_rhythm"><div><b>Face Equality International</b></div><div>United Kingdom</div><div><b>Email:</b> info@faceequalityinternational.org</div><div><a href="https://faceequalityinternational.org/thealliance/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.faceequalityinternational.org</a></div></li><li class="half_rhythm"><div><b>FACES: The National Craniofacial Association</b></div><div>PO Box 11082</div><div>Chattanooga TN 37401</div><div><b>Phone:</b> 800-332-2373 (toll-free)</div><div><b>Email:</b> faces@faces-cranio.org</div><div><a href="http://www.faces-cranio.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.faces-cranio.org</a></div></li></ul></div><div id="gcps.Molecular_Genetics"><h2 id="_gcps_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="gcps.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Greig Cephalopolysyndactyly Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1446/table/gcps.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gcps.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_gcps.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_gcps.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_gcps.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_gcps.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_gcps.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_gcps.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_gcps.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2737" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>GLI3</i></a></td><td headers="hd_b_gcps.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2737" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7p14<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_gcps.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P10071" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Transcriptional activator GLI3</a></td><td headers="hd_b_gcps.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/GLI3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GLI3 @ LOVD</a></td><td headers="hd_b_gcps.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GLI3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GLI3</a></td><td headers="hd_b_gcps.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=GLI3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GLI3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="gcps.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="gcps.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Greig Cephalopolysyndactyly Syndrome (<a href="/omim/165240,175700" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1446/table/gcps.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gcps.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/165240" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">165240</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GLI-KRUPPEL FAMILY MEMBER 3; GLI3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/175700" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">175700</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS</td></tr></tbody></table></div></div><div id="gcps.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>Alterations that cause Greig cephalopolysyndactyly syndrome (GCPS) range from gross <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> alterations to nucleic acid substitutions.</p><p><b>Gene structure.</b>
<i>GLI3</i> is large, with exons spanning at least 296 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA on the minus strand of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 7, from 41,967,073 to 42,243,321 bp and comprising at least 15 exons in the current human genome build (<a href="http://genome.ucsc.edu/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">genome.ucsc.edu</a>; March 2006 build). The current reference sequence for the <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> is an 8,228-nt sequence: <a href="/nuccore/NM_000168.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000168.5</a>. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1446/#gcps.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> A number of putative benign variants exist in <i>GLI3</i> (see <a href="/books/NBK1446/bin/gcps-Table2.pdf">Table 2</a> [pdf]). Most of the variants have been seen in multiple unrelated persons and are not believed to be associated with any phenotypic effects, although they have not been rigorously analyzed for subtle effects. They are included in <a href="/books/NBK1446/bin/gcps-Table2.pdf">Table 2</a> if they lie within an <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or if they are in an <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> within 25 bp of an exon. Readers should refer to dbSNP to confirm these data and for additional data (SNPs are from Human Genome build 126).</p><p><b>Pathogenic variants.</b> A large variety of published pathogenic variants has been reported including cytogenetically visible translocations, interstitial deletions of 7p13, small insertions or deletions that cause frameshifts and premature truncation, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants, variants that alter a <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>, and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants that change an amino acid [<a class="bk_pop" href="#gcps.REF.wild.1997.1979">Wild et al 1997</a>, <a class="bk_pop" href="#gcps.REF.kalffsuske.1999.1769">Kalff-Suske et al 1999</a>, <a class="bk_pop" href="#gcps.REF.elson.2002.804">Elson et al 2002</a>, <a class="bk_pop" href="#gcps.REF.debeer.2003.49">Debeer et al 2003</a>, <a class="bk_pop" href="#gcps.REF.johnston.2005.609">Johnston et al 2005</a>]. (For more information, see <a href="/books/NBK1446/#gcps.molgen.TA">Table A</a>.)</p><p>Selected pathogenic variants reported in individuals with GCPS are listed in <a href="/books/NBK1446/bin/gcps-Table3.pdf">Table 3</a> (pdf). Multiple new pathogenic variants have been identified by <a class="bk_pop" href="#gcps.REF.johnston.2005.609">Johnston et al [2005]</a>. See <a class="figpopup" href="/books/NBK1446/table/gcps.T.selected_gli3_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figgcpsTselectedgli3pathogenicvariants" rid-ob="figobgcpsTselectedgli3pathogenicvariants">Table 4</a>.</p><div id="gcps.T.selected_gli3_pathogenic_variants" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Selected <i>GLI3</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1446/table/gcps.T.selected_gli3_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gcps.T.selected_gli3_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.540_547del</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn181CysfsTer15<br />(A181_T183delinsCfsTer15)</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_3" rowspan="20" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?val=NM_000168.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000168<wbr style="display:inline-block"></wbr>​.5</a><br /><a href="/entrez/viewer.fcgi?val=NP_000159.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000159<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.658delC</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg220ValfsTer3</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.679+2_679+15del14del14</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.827-3C&#x0003e;G</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.868C&#x0003e;T</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg290Ter</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1048dupT<br />(1048_1049insT)</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr350LeufsTer62</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1074delC</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His358GlnfsTer7</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1497+1G&#x0003e;C</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1617_1633del</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg539SerfsTer7<br />(R539_P545delinsSfsTer7)</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1789C&#x0003e;T</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln597Ter</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1880_1881delAT</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His627ArgfsTer48</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2374C&#x0003e;T</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg792Ter</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4119_4123delinsAGCCTGA<br />(4119_4123delins7)</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro1374AlafsTer2<br />(P1374_S1375delinsAfsTer2)</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4403dupT<br />(4402_4403insT)</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu1469AlafsTer10</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4427delA</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn1476ThrfsTer12<br />(S1477LfsTer11)</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4564delG</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala1522ProfsTer2</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4677dupC<br />(4677_4678insC)</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly1560ArgfsTer38</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1446C&#x0003e;G</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys482Trp</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1874G&#x0003e;A</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg625Gln</td></tr><tr><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1873C&#x0003e;T</td><td headers="hd_h_gcps.T.selected_gli3_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg625Trp</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><a class="bk_pop" href="#gcps.REF.johnston.2005.609">Johnston et al [2005]</a></p></div></dd><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="gcps.TF.4.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The gene encodes a protein of 1,580 amino acids.</p><p>Note: As the result of a <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> sequencing error, older citations described a longer <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a> that predicted a protein of 1,596 amino acids; the error was corrected in the GenBank entry NM_000168.3 and in subsequent versions of this sequence.</p><p><i>GLI3</i> encodes a zinc finger <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a> that is downstream of Sonic Hedgehog in SHH pathway (SHH-PTCH1-SMO-GLI1, GLI2, GLI3) [<a class="bk_pop" href="#gcps.REF.villavicencio.2000.1047">Villavicencio et al 2000</a>]. The various GLI proteins in turn regulate genes further downstream in this pathway, including HNF3&#x003b2;, bone morphogenetic proteins, and other as-yet-unknown targets. The human <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is similar to the mouse paralog <i>Gli3</i> and the vertebrate <i>GLI</i> gene family is homologous to the <i>Drosophila melanogaster</i> gene cubitus interruptus (ci).</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The most common, if not sole, pathogenetic mechanism for GCPS is <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>. Deletions that remove the entire gene cause a GCPS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> that is not known to be different from that caused by single nucleotide variants. In addition, mouse models support the hypothesis that haploinsufficiency is the mechanism. Although it is clear that haploinsufficiency of <i>GLI3</i> can cause GCPS, the pathogenic mechanism of 3' frameshift or <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants is not clear.</p><p>It is important to note that <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> or protein instability may be caused by some of these pathogenic variants in individuals with GCPS, a finding that would be entirely compatible with the general mechanism of <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>.</p></div></div><div id="gcps.References"><h2 id="_gcps_References_">References</h2><div id="gcps.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.allanson.2009.6">Allanson JE, Cunniff C, Hoyme HE, McGaughran J, Muenke M, Neri G. Elements of morphology: standard terminology for the head and face. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:6–28.</span> [<a href="/pmc/articles/PMC2778021/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2778021</span></a>] [<a href="/pubmed/19125436" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19125436</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.biesecker.2008.10">Biesecker LG. The Greig cephalopolysyndactyly syndrome. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2008;<span class="ref-vol">3</span>:10.</span> [<a href="/pmc/articles/PMC2397380/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2397380</span></a>] [<a href="/pubmed/18435847" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18435847</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.biesecker.2009.93">Biesecker LG, Aase JM, Clericuzio C, Gurrieri F, Temple IK, Toriello H. Elements of morphology: standard terminology for the hands and feet. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:93–127.</span> [<a href="/pmc/articles/PMC3224990/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3224990</span></a>] [<a href="/pubmed/19125433" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19125433</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.bilguvar.2007.495">Bilguvar K, Bydon M, Bayrakli F, Ercan-Sencicek AG, Bayri Y, Mason C, DiLuna ML, Seashore M, Bronen R, Lifton RP, State M, Gunel M. A novel syndrome of cerebral cavernous malformation and Greig cephalopolysyndactyly. Laboratory investigation. <span><span class="ref-journal">J Neurosurg. </span>2007;<span class="ref-vol">107</span>:495–9.</span> [<a href="/pubmed/18154020" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18154020</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.debeer.2003.49">Debeer P, Peeters H, Driess S, De Smet L, Freese K, Matthijs G, Bornholdt D, Devriendt K, Grzeschik KH, Fryns JP, Kalff-Suske M. Variable phenotype in Greig cephalopolysyndactyly syndrome: clinical and radiological findings in 4 independent families and 3 sporadic cases with identified GLI3 mutations. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">120A</span>:49–58.</span> [<a href="/pubmed/12794692" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12794692</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.elson.2002.804">Elson E, Perveen R, Donnai D, Wall S, Black GC. De novo GLI3 mutation in acrocallosal syndrome: broadening the phenotypic spectrum of GLI3 defects and overlap with murine models. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:804–6.</span> [<a href="/pmc/articles/PMC1735022/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735022</span></a>] [<a href="/pubmed/12414818" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12414818</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.everman.2006">Everman DB. Hands and feet. In: Stevenson RE, Hall JG, eds. <em>Human Malformations and Related Anomalies.</em> 2 ed. New York: Oxford University Press; 2006:935-96.</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.gorlin.2001">Gorlin RJ, Cohen MM Jr, Hennekam RCM. Greig cephalopolysyndactyly syndrome. In: <em>Syndromes of the Head and Neck</em>. New York: Oxford University Press; 2001:995-6.</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.hall.2009.29">Hall BD, Graham JM Jr, Cassidy SB, Opitz JM. Elements of morphology: standard terminology for the periorbital region. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:29–39.</span> [<a href="/pubmed/19125427" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19125427</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.johnston.2007.e59">Johnston JJ, Walker RL, Davis S, Facio F, Turner JT, Bick DP, Daentl DL, Ellison JW, Meltzer PS, Biesecker LG. Zoom-in comparative genomic hybridisation arrays for the characterisation of variable breakpoint contiguous gene syndromes. <span><span class="ref-journal">J Med Genet. </span>2007;<span class="ref-vol">44</span>:e59.</span> [<a href="/pmc/articles/PMC2597909/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2597909</span></a>] [<a href="/pubmed/17098889" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17098889</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.johnston.2005.609">Johnston JJ, Olivos-Glander I, Killoran C, Elson E, Turner JT, Peters KF, Abbott MH, Aughton DJ, Aylsworth AS, Bamshad MJ, Booth C, Curry CJ, David A, Dinulos MB, Flannery DB, Fox MA, Graham JM, Grange DK, Guttmacher AE, Hannibal MC, Henn W, Hennekam RC, Holmes LB, Hoyme HE, Leppig KA, Lin AE, Macleod P, Manchester DK, Marcelis C, Mazzanti L, McCann E, McDonald MT, Mendelsohn NJ, Moeschler JB, Moghaddam B, Neri G, Newbury-Ecob R, Pagon RA, Phillips JA, Sadler LS, Stoler JM, Tilstra D, Walsh Vockley CM, Zackai EH, Zadeh TM, Brueton L, Black GC, Biesecker LG. Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">76</span>:609–22.</span> [<a href="/pmc/articles/PMC1199298/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1199298</span></a>] [<a href="/pubmed/15739154" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15739154</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.johnston.2003.236">Johnston JJ, Olivos-Glander I, Turner J, Aleck K, Bird LM, Mehta L, Schimke RN, Heilstedt H, Spence JE, Blancato J, Biesecker LG. Clinical and molecular delineation of the Greig cephalopolysyndactyly contiguous gene deletion syndrome and its distinction from acrocallosal syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">123A</span>:236–42.</span> [<a href="/pubmed/14608643" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14608643</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.kalffsuske.1999.1769">Kalff-Suske M, Wild A, Topp J, Wessling M, Jacobsen EM, Bornholdt D, Engel H, Heuer H, Aalfs CM, Ausems MG, Barone R, Herzog A, Heutink P, Homfray T, Gillessen-Kaesbach G, K&#x000f6;nig R, Kunze J, Meinecke P, M&#x000fc;ller D, Rizzo R, Strenge S, Superti-Furga A, Grzeschik KH. Point mutations throughout the GLI3 gene cause Greig cephalopolysyndactyly syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>1999;<span class="ref-vol">8</span>:1769–77.</span> [<a href="/pubmed/10441342" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10441342</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.kang.1997.266">Kang S, Graham JM Jr, Olney AH, Biesecker LG. GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. <span><span class="ref-journal">Nat Genet. </span>1997;<span class="ref-vol">15</span>:266–8.</span> [<a href="/pubmed/9054938" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9054938</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.koenig.2002.7">Koenig R, Bach A, Woelki U, Grzeschik KH, Fuchs S. Spectrum of the acrocallosal syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">108</span>:7–11.</span> [<a href="/pubmed/11857542" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11857542</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.kroisel.2001.243">Kroisel PM, Petek E, Wagner K. Phenotype of five patients with Greig syndrome and microdeletion of 7p13. <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">102</span>:243–9.</span> [<a href="/pubmed/11484201" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11484201</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.putoux.2011.601">Putoux A, Thomas S, Coene KL, Davis EE, Alanay Y, Ogur G, Uz E, Buzas D, Gomes C, Patrier S, Bennett CL, Elkhartoufi N, Frison MH, Rigonnot L, Joy&#x000e9; N, Pruvost S, Utine GE, Boduroglu K, Nitschke P, Fertitta L, Thauvin-Robinet C, Munnich A, Cormier-Daire V, Hennekam R, Colin E, Akarsu NA, Bole-Feysot C, Cagnard N, Schmitt A, Goudin N, Lyonnet S, Encha-Razavi F, Siffroi JP, Winey M, Katsanis N, Gonzales M, Vekemans M, Beales PL, Atti&#x000e9;-Bitach T. KIF7 mutations cause fetal hydrolethalus and acrocallosal syndromes. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>:601–6.</span> [<a href="/pmc/articles/PMC3674836/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3674836</span></a>] [<a href="/pubmed/21552264" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21552264</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.speksnijder.2013.1394">Speksnijder L, Cohen-Overbeek TE, Knapen MF, Lunshof SM, Hoogeboom AJ, van den Ouwenland AM, de Coo IF, Lequin MH, Bolz HJ, Bergmann C, Biesecker LG, Willems PJ, Wessels MW. A de novo GLI3 mutation in a patient with acrocallosal syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:1394–400.</span> [<a href="/pubmed/23633388" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23633388</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.villavicencio.2000.1047">Villavicencio EH, Walterhouse DO, Iannaccone PM. The sonic hedgehog-patched-gli pathway in human development and disease. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">67</span>:1047–54.</span> [<a href="/pmc/articles/PMC1288546/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1288546</span></a>] [<a href="/pubmed/11001584" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11001584</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gcps.REF.wild.1997.1979">Wild A, Kalff-Suske M, Vortkamp A, Bornholdt D, K&#x000f6;nig R, Grzeschik KH. Point mutations in human GLI3 cause Greig syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>1997;<span class="ref-vol">6</span>:1979–84.</span> [<a href="/pubmed/9302279" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9302279</span></a>]</div></li></ul></div></div><div id="gcps.Chapter_Notes"><h2 id="_gcps_Chapter_Notes_">Chapter Notes</h2><div id="gcps.Author_Notes"><h3>Author Notes</h3><p><a href="https://www.genome.gov/staff/Leslie-G-Biesecker-MD" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Author's web page</a></p></div><div id="gcps.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>19 June 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>30 April 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>14 August 2006 (lgb) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> clinically available</div></li><li class="half_rhythm"><div>7 February 2006 (lgb) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>GLI3</i> clinically available</div></li><li class="half_rhythm"><div>20 September 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>7 October 2004 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>-metaphase clinically available</div></li><li class="half_rhythm"><div>25 August 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 July 2001 (me) Review posted live</div></li><li class="half_rhythm"><div>20 February 2001 (lgb) Original submission</div></li></ul><p>Note: Pursuant to 17 USC Section 105 of the United States Copyright Act, the <i>GeneReview</i> "Greig Cephalopolysyndactyly Syndrome" is in the public <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> in the United States of America.</p></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1446</span><span class="label">PMID: <a href="/pubmed/20301619" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301619</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/gsd6/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hemochromatosis/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1446&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1446/?report=reader">PubReader</a></li><li><a href="/books/NBK1446/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1446" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1446" style="display:none" title="Cite this Page"><div class="bk_tt">Biesecker LG. Greig Cephalopolysyndactyly Syndrome. 2001 Jul 9 [Updated 2014 Jun 19]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1446/pdf/Bookshelf_NBK1446.pdf">PDF version of this page</a> (458K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#gcps.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#gcps.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#gcps.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#gcps.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#gcps.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#gcps.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#gcps.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#gcps.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#gcps.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#gcps.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#gcps.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2737[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GLI3</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1471512" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1471512" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1471512" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1471512" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31573334" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Variants in &lt;i&gt;GLI3&lt;/i&gt; Cause Greig Cephalopolysyndactyly Syndrome.</a><span class="source">[Genet Test Mol Biomarkers. 2019]</span><div class="brieflinkpop offscreen_noflow">Variants in &lt;i&gt;GLI3&lt;/i&gt; Cause Greig Cephalopolysyndactyly Syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Abdullah, Yousaf M, Azeem Z, Bilal M, Liaqat K, Hussain S, Ahmad F, Ghous T, Ullah A, Ahmad W. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Genet Test Mol Biomarkers. 2019 Oct; 23(10):744-750. Epub 2019 Oct 1.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/18435847" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> The Greig cephalopolysyndactyly syndrome.</a><span class="source">[Orphanet J Rare Dis. 2008]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> The Greig cephalopolysyndactyly syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Biesecker LG. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Orphanet J Rare Dis. 2008 Apr 24; 3:10. Epub 2008 Apr 24.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/9054938" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome.</a><span class="source">[Nat Genet. 1997]</span><div class="brieflinkpop offscreen_noflow">GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kang S, Graham JM Jr, Olney AH, Biesecker LG. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Nat Genet. 1997 Mar; 15(3):266-8. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/18241058" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">The clinical atlas of Greig cephalopolysyndactyly syndrome.</a><span class="source">[Am J Med Genet A. 2008]</span><div class="brieflinkpop offscreen_noflow">The clinical atlas of Greig cephalopolysyndactyly syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Balk K, Biesecker LG. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2008 Mar 1; 146A(5):548-57. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301638" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pallister-Hall Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pallister-Hall Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Biesecker LG. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301619" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301619" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042909dde0891169981895">Greig Cephalopolysyndactyly Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Greig Cephalopolysyndactyly Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:29:13-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8C9BB7E042304100000000029D0104&amp;ncbi_session=CE8C9BB7E0429091_0669SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1446%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1446&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1446/&amp;ncbi_pagename=Greig Cephalopolysyndactyly Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C9BB7E0429091_0669SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>